WallStreetZenWallStreetZen

NASDAQ: TXMD
Therapeuticsmd Inc Stock

$3.86+0.02 (+0.52%)
Updated May 26, 2023
TXMD Price
$3.86
Fair Value Price
$6.76
Market Cap
$38.42M
52 Week Low
$3.25
52 Week High
$11.69
P/E
0.22x
P/B
1.2x
P/S
0.72x
PEG
N/A
Dividend Yield
N/A
Revenue
$51.05M
Earnings
$157.42M
Gross Margin
106.8%
Operating Margin
280.24%
Profit Margin
308.4%
Debt to Equity
0.86
Operating Cash Flow
-$8M
Beta
1.35
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TXMD Overview

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TXMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TXMD ($3.86) is undervalued by 42.93% relative to our estimate of its Fair Value price of $6.76 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TXMD ($3.86) is significantly undervalued by 42.93% relative to our estimate of its Fair Value price of $6.76 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
TXMD is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TXMD due diligence checks available for Premium users.

Be the first to know about important TXMD news, forecast changes, insider trades & much more!

TXMD News

Valuation

TXMD fair value

Fair Value of TXMD stock based on Discounted Cash Flow (DCF)
Price
$3.86
Fair Value
$6.76
Undervalued by
42.93%
TXMD ($3.86) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TXMD ($3.86) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TXMD is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TXMD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0.22x
Industry
14.7x
Market
54.23x
TXMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TXMD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

TXMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.2x
Industry
1.74x
TXMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TXMD's financial health

Profit margin

Revenue
$416.0k
Net Income
-$3.6M
Profit Margin
-866.1%
TXMD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TXMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$59.6M
Liabilities
$27.6M
Debt to equity
0.86
TXMD's short-term assets ($24.74M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TXMD's short-term assets ($24.74M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TXMD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
TXMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$33.2M
Investing
$0.0
Financing
$1.1M
TXMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TXMD vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
TXMD$38.42M+0.52%0.22x1.20x
HUGE$38.52M-4.17%-1.84x2.51x
MNK$39.51M+2.04%N/A0.03x
QLI$36.11M+1.00%33.67x0.68x
NLTX$35.12M+1.23%-0.80x0.43x

Therapeuticsmd Stock FAQ

What is Therapeuticsmd's quote symbol?

(NASDAQ: TXMD) Therapeuticsmd trades on the NASDAQ under the ticker symbol TXMD. Therapeuticsmd stock quotes can also be displayed as NASDAQ: TXMD.

If you're new to stock investing, here's how to buy Therapeuticsmd stock.

What is the 52 week high and low for Therapeuticsmd (NASDAQ: TXMD)?

(NASDAQ: TXMD) Therapeuticsmd's 52-week high was $11.69, and its 52-week low was $3.25. It is currently -66.98% from its 52-week high and 18.77% from its 52-week low.

How much is Therapeuticsmd stock worth today?

(NASDAQ: TXMD) Therapeuticsmd currently has 9,953,290 outstanding shares. With Therapeuticsmd stock trading at $3.86 per share, the total value of Therapeuticsmd stock (market capitalization) is $38.42M.

Therapeuticsmd stock was originally listed at a price of $1.20 in Dec 2, 2011. If you had invested in Therapeuticsmd stock at $1.20, your return over the last 11 years would have been 221.67%, for an annualized return of 11.21% (not including any dividends or dividend reinvestments).

How much is Therapeuticsmd's stock price per share?

(NASDAQ: TXMD) Therapeuticsmd stock price per share is $3.86 today (as of May 26, 2023).

What is Therapeuticsmd's Market Cap?

(NASDAQ: TXMD) Therapeuticsmd's market cap is $38.42M, as of May 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Therapeuticsmd's market cap is calculated by multiplying TXMD's current stock price of $3.86 by TXMD's total outstanding shares of 9,953,290.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.